Crossref
Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test
BMJ · 2024
DOI: 10.1136/bmj.q744 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMJ, 2024. Verfasst von Elisabeth Mahase. Beteiligte Einrichtung: The BMJ. Hauptthemen laut MEDLINE: Advertising, Diabetes Mellitus, Type 1. Die Arbeit nennt 3 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AdvertisingDiabetes Mellitus, Type 1HumansAcetamidesFear
Substanzen
CDAAAcetamides
Autor:innen und Institutionen
- The BMJ.
Zitieren
APA
Mahase, E. (2024). Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test. BMJ. https://doi.org/10.1136/bmj.q744
Vancouver
Mahase E. Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test. BMJ. 2024. doi:10.1136/bmj.q744
BibTeX
@article{Mahase2024,
author = {Mahase, Elisabeth},
title = {Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test},
journal = {BMJ},
year = {2024},
doi = {10.1136/bmj.q744}
}
EUVIMED